Khushali Jhaveri

Khushali Jhaveri

Hematologist, Medical Oncologist

Lymphoma

Indiana University Health

USA, Indianapolis

  • Assistant Professor of Medicine,
  • Division of Hematology and Oncology,
  • Indiana University Health / Indiana University School of Medicine,
    Indianapolis, IN, USA
YearsDegree / TrainingInstitutionLocation

Education & Training
2009 – 2015Bachelor of Medicine and Bachelor of Surgery (MBBS) – Ranked Top 10 Medical SchoolB.J. Medical CollegeAhmedabad, India
2017 – 2021Residency in Internal Medicine – ACGME-Accredited ProgramMedStar Washington Hospital CenterWashington, DC, USA
2021 – 2024Fellowship in Hematology & Medical Oncology – Moffitt Cancer Center / University of South Florida (ACGME-Accredited)University of South Florida (Moffitt Cancer Center)Tampa, FL, USA

Professional Positions  Employment
Sept 2024 – PresentAssistant Professor of MedicineIndiana University HealthIndianapolis, IN
Jul 2021 – Jun 2024Hematology / Oncology Fellow Physician – Chief Fellow for Communication & WellnessMoffitt Cancer Center / University of South FloridaTampa, FL
Jun 2017 – Apr 2021Resident Physician, Internal Medicine (Program Director: Dr. Sailaja Pindiprolu)MedStar Washington Hospital CenterWashington, DC

National Committees, Panels, and Professional Memberships
Panel Member – NCCN Guidelines Panel for Hematopoietic Growth Factors (Representative of Indiana University Melvin and Bren Simon Comprehensive Cancer Center)National Comprehensive Cancer Network (NCCN)Apr 2025 – Present
Full Member – Sigma Xi, The Scientific Research Honor SocietySigma Xi – Scientific Research Honor SocietyMay 2025 – Present
Member – Lymphoma Clinical Trial Working GroupMoffitt Cancer CenterMar 2025 – Present
Special Member – SWOG Cancer Research NetworkSWOGAug 2025 – Present
Member – Big Ten Clinical Trial Working GroupHoosier Cancer Research Network (HCRN)May 2025 – Present
Associate Editor – ASH Clinical News Editorial BoardAmerican Society of Hematology (ASH)Jan 2026 – Dec 2028
Nominated – ASH Committee on Communications (2025 Cycle)American Society of Hematology2025
Fellow Representative – Moffitt GMEC CommitteeUniversity of South Florida / Moffitt Cancer Center2021 – 2024
Chief Fellow – Communication and WellnessMoffitt Cancer Center Fellowship Program2022 – 2024

Honors & Awards
2025Selected Participant – AbbVie Clinical Trial WorkshopAbbVie OncologyCompetitively chosen for national oncology clinical trial development program
2025Full Member – Sigma Xi, The Scientific Research Honor SocietySigma XiElected for scientific contributions and research achievement
2025Featured Article – Medscape MedBriefMedscape“Lymphoma: Muscle Mass May Presage CAR T Outcomes” – Highlight summarizing original research in Clinical Cancer Research
2020Winner – Oral Podium PresentationAmerican College of Physicians (DC Chapter)Impact of Surveillance and Offered ID Consults for Staphylococcus Aureus Bacteremia on Quality-of-Care Indicators
2018Poster of Distinction – Digestive Diseases WeekDDWSignificant Variation in Detection Rates of Proximal Serrated Polyps Among Academic and Community Gastroenterologists and Surgeons
2007Top 3 Women in Gujarat State High School Board ExaminationGovernment of GujaratAwarded by Prime Minister Narendra Modi for academic excellence

Clinical Trials
Institutional Principal InvestigatorSWOGS2308: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular LymphomaAug 2025 – Present
Sub-InvestigatorECOG-ACRINEA4232 (PTCL-STAT): Randomized Phase III Trial of Autologous Stem Cell Transplant vs. Observation in PTCL in CR1Apr 2025 – Present
Sub-InvestigatorHoosier Cancer Research Network (HCRN)LYM22001: Phase II Trial of Epcoritamab + GDP in R/R Large B-Cell LymphomaOct 2024 – Present
Sub-InvestigatorRegeneronOLYMPIA-3: Phase III Trial of Odronextamab + CHOP vs. R-CHOP in Previously Untreated DLBCLOct 2024 – Present
Sub-InvestigatorRegeneronOLYMPIA-5: Phase III Trial of Odronextamab + Lenalidomide vs. Rituximab + Lenalidomide in R/R FL and MZLOct 2024 – Present
Sub-InvestigatorAbbVieM23-324: First-in-Human Study of ABBV-525 (MALT1 Inhibitor) in B-Cell MalignanciesOct 2024 – Present
Sub-InvestigatorSWOG / NCIS1925 (EVOLVE CLL/SLL): Randomized Phase III Trial of Early vs. Delayed Venetoclax + Obinutuzumab in High-Risk CLL/SLLOct 2024 – Present
Sub-InvestigatorInvestigator-InitiatedCD4CAR: Phase I Study of CD4-Directed CAR T Cells in R/R CD4⁺ Hematologic MalignanciesOct 2024 – Present
Sub-InvestigatorECOG-ACRIN / NCIECOG MyeloMATCH: NCI Precision Oncology Trial for Myeloid MalignanciesOct 2024 – Present

Research Projects
Baseline Body Composition and Outcomes in Patients Treated with Bispecific AntibodiesPrincipal InvestigatorJul 2025 – Present
Evaluation of Sarcopenia and Body Composition Markers as Predictors of CAR T OutcomesPrincipal InvestigatorJan 2022 – Jan 2025
Influence of Adipose Tissue Distribution and Nutrition on CAR T Outcomes – Multi-Center StudyCo-InvestigatorAug 2022 – Dec 2022
Incidence Trends of Anal Squamous Cell Carcinoma (SEER Data)Principal InvestigatorNov 2019 – Mar 2020
Population Study of Hemolytic Uremic Syndrome (NIS Data 2019–2020)Principal InvestigatorJan – Mar 2023
Population Study of Thrombotic Microangiopathy HospitalizationsPrincipal InvestigatorJan – Mar 2023
Impact of C. Difficile on VTE Outcomes (NIS 2016)Principal InvestigatorSept 2019 – Feb 2020
Impact of Surveillance and ID Consults for S. aureus BacteremiaCo-Principal InvestigatorJan 2020 – Jul 2020
Post-Surgical Outcomes in Endocarditis with Liver Disease (NIS 2016)Co-InvestigatorJan 2020 – Sept 2020
Adenoma and Proximal Serrated Polyp Detection Rates – Tertiary Care StudyCo-InvestigatorAug 2017 – Oct 2018

Invited Lectures & Oral Presentations
Impact of Surveillance and Offered ID Consults for Staphylococcus Aureus Bacteremia on Quality of Care Indicators – 1st Place Oral Podium PresentationAmerican College of Physicians (DC Chapter)Washington, DC2020

Editorial & Scholarly Activities

  • Associate Editor, ASH Clinical News (2026 – 2028)
  • Contributor, Medscape MedBrief and ABC News Medical Unit
  • Invited Speaker – AbbVie Clinical Trial Workshop (2025)
  • Reviewer – Peer scientific abstracts for national oncology conferences

Research & Clinical Interests

  • Hematologic malignancies and lymphoma
  • Cellular and gene therapy development
  • Clinical trial design and implementation
  • Translational hematology and growth factor biology
  • Physician wellness and communication in medical training

Accepted & Published Media Articles

  • A Young Hematologist’s Take on ICML 2025. ASCO Post.
  • It’s Time to Prescribe Exercise Like We Prescribe Chemotherapy. Doximity.
  • Bearing Witness: The Silent Weight of Moral Injury in Oncology. ASH Clinical News.
  • Are We on the Brink of Redefining Follicular Lymphoma? Medscape.
  • Redefining Home, Embracing Resilience: Life as an Immigrant in Medicine. ASH Clinical News.
  • Cost of Survival: How Treatment Choices Shape Life After Cancer. Medscape.
  • Anti-Aging Medication Could Help Dogs Live Longer. ABC News.
  • Skin-to-Skin Contact Critical for Premature Babies. ABC News.
  • Cannabis Use Does Not Reduce Long-Term Heroin Use. ABC News.
  • Heat-Related Deaths for Older Adults Could Increase 370% by Mid-Century. ABC News.
  • Fertility Preservation for Cancer Patients at Risk Amid Abortion Debate. ABC News.
  • PFAS Chemicals in School Uniforms. ABC News.
  • Updated Boosters for Children Weeks from Authorization. ABC News. (with Cheyenne Haslett & Sony Salzman)

Poster Presentations

  • 17-Year Incidence Trends of Anal Squamous Cell Carcinoma – ASCO 2020
  • Impact of Pulmonary Hypertension on Sickle Cell Disease Hospitalizations – ASH 2020
  • Impact of C. Difficile Infection on VTE Outcomes – ISTH 2020
  • NSTEMI after ATRA/ATO Induction for APML – CHEST 2020
  • Impact of Surveillance and ID Consults in S. Aureus Bacteremia – ID Week 2020
  • Dyspnea in a Smoker – Why So Blue? – CHEST 2020
  • High Anion Gap Metabolic Acidosis – What Can It Be? – CHEST Congress 2019

Peer-Reviewed Publications

  1. Winkelmann M et al., Jhaveri K, et al. Optimization and Validation of the International Metabolic Prognostic Index for CD19 CAR-T in Large B-Cell Lymphoma. Blood Cancer J. 2025; 15(1):144. PMID 40858552.
  2. Jhaveri K et al. Sarcopenia and Skeletal Muscle Loss after CAR T-Cell Therapy in DLBCL. Clin Cancer Res. 2025. PMID 40238583.
  3. Saha A, Jhaveri K et al. Tisagenlecleucel: CAR-T Cell Therapy for Relapsed or Refractory Follicular Lymphoma.Expert Opin Biol Ther. 2023; 23(9):869-876.
  4. Sarfraz H, Saha A, Jhaveri K, Kim D.W. Review of Current and Novel Systemic Therapies for Pancreatic Ductal Adenocarcinoma. Curr Oncol. 2023; 30(6):5322-5336.
  5. Rejeski K et al., Jhaveri K. Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Outcomes after CD19 CAR T-Cell Therapy. Cancer Immunol Res. 2023; 11(6):707-719.
  6. Jhaveri K et al. Safety and Efficacy of CAR T Cells in a Patient with Lymphoma and Autoimmune Neuropathy.Blood Adv. 2020; 4(23):6019-6022.
  7. Jhaveri K et al. Impact of Clostridium Difficile Infections on In-Hospital Outcomes of Venous Thromboembolism Hospitalizations. Cureus. 2020; 12(7):e9195.
  8. Jhaveri K et al. Association of the Food Environment and Cardiovascular Mortality. F1000Research. 2020; 9:643.
  9. Kosuru V, Jhaveri K et al. Metastatic Calcinosis of Gastric Mucosa. J Investig Med High Impact Case Rep.2020; 8:2324709620940482.
  10. Jhaveri K et al. A Pain in the Neck – Intramedullary Spinal Ependymoma. Cureus. 2020; 12(5):e7981.
  11. Ludhwani D, Jhaveri K et al. Atypical Takotsubo Cardiomyopathy: Case Report and Review. Curr Cardiol Rev.2020; 16(3):241-246.
  12. Jhaveri K et al. Primary Pulmonary Involvement in MALT Lymphoma. Cureus. 2019; 11(7):e5110.
  13. Mandaliya R et al., Jhaveri K. Variation in Detection Rates of Proximal Serrated Polyps Across Specialties. Dig Dis Sci. 2019; 64(9):2614-2621.
  14. Jhaveri K et al. Isolated Splenic Sarcoidosis: A Rare Case Report. Case Rep Med. 2018; 2018:4628439.

Book Chapters

  1. Jhaveri K, Gaballa S. Follicular Lymphoma. In Handbook of Hematologic Malignancies, 3rd ed. Springer, 2024.
  2. Jhaveri K, Sokol L. Extranodal Natural Killer/T-Cell Lymphoma. In Handbook of Hematologic Malignancies, 3rd ed. Springer, 2024.

Office Address, Telephone & Work Email

Office address: Indiana University Health, Department of Medicine
Division of Hematology and Oncology
Indianapolis, Indiana 46202, USA

Work email: [email protected]